A modest increase in the inhibition of HIV-1 infection by the CA-targeting compound BI-2 could be observed in IPMK KO cells at concentrations of >100 μM; however, at this concentration, the specificity of the drug becomes difficult to assess owing to cytotoxicity (Fig. 2E). This evidence concerns the gene IPMK and HIV-1 infection.